Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 159

1.

Association of a rare variant of the TNFSF13B gene with susceptibility to Rheumatoid Arthritis and Systemic Lupus Erythematosus.

González-Serna D, Ortiz-Fernández L, Vargas S, García A, Raya E, Fernández-Gutierrez B, López-Longo FJ, Balsa A, González-Álvaro I, Narvaez J, Gómez-Vaquero C, Sabio JM, García-Portales R, González-Escribano MF, Tolosa C, Carreira P, Kiemeney L, Coenen MJH, Witte T, Schneider M, González-Gay MÁ, Martín J.

Sci Rep. 2018 May 29;8(1):8195. doi: 10.1038/s41598-018-26573-4.

2.

Treatment with methotrexate and risk of relapses in patients with giant cell arteritis in clinical practice.

Leon L, Rodriguez-Rodriguez L, Morado I, Rosales Z, Vadillo C, Freites D, Macarron P, Fernandez-Gutierrez B, Blanco M, Jover JA, Abasolo L.

Clin Exp Rheumatol. 2018 Mar-Apr;36 Suppl 111(2):121-128. Epub 2017 Dec 6.

PMID:
29303708
3.

Disease Remission in Children and Adolescents with Intermediate Uveitis: A Survival Analysis.

Borrego-Sanz L, Abásolo L, López-Abad C, Fernández-Gutiérrez B, García-Feijoo J, Diaz-Valle D, Pato E, Rodriguez-Rodriguez L.

Ophthalmologica. 2018;239(2-3):151-158. doi: 10.1159/000485262. Epub 2017 Dec 14.

PMID:
29241207
4.

Osteoarthritis in Spain: A nationwide survey of medical specialists.

Arriaza R, Sancho C, Fernandez-Gutierrez B.

Reumatol Clin. 2017 Nov 25. pii: S1699-258X(17)30265-6. doi: 10.1016/j.reuma.2017.10.006. [Epub ahead of print] English, Spanish.

5.

Genetic variation associated with cardiovascular risk in autoimmune diseases.

Perrotti PP, Aterido A, Fernández-Nebro A, Cañete JD, Ferrándiz C, Tornero J, Gisbert JP, Domènech E, Fernández-Gutiérrez B, Gomollón F, García-Planella E, Fernández E, Sanmartí R, Gratacós J, Martínez-Taboada VM, Rodríguez-Rodríguez L, Palau N, Tortosa R, Corbeto ML, Lasanta ML, Marsal S, Julià A; IMID Consortium.

PLoS One. 2017 Oct 5;12(10):e0185889. doi: 10.1371/journal.pone.0185889. eCollection 2017.

6.

Development and validation of a multivariate predictive model for rheumatoid arthritis mortality using a machine learning approach.

Lezcano-Valverde JM, Salazar F, León L, Toledano E, Jover JA, Fernandez-Gutierrez B, Soudah E, González-Álvaro I, Abasolo L, Rodriguez-Rodriguez L.

Sci Rep. 2017 Aug 31;7(1):10189. doi: 10.1038/s41598-017-10558-w.

7.

Cardiovascular disease in immune-mediated inflammatory diseases: A cross-sectional analysis of 6 cohorts.

Fernández-Gutiérrez B, Perrotti PP, Gisbert JP, Domènech E, Fernández-Nebro A, Cañete JD, Ferrándiz C, Tornero J, García-Sánchez V, Panés J, Fonseca E, Blanco F, Rodríguez-Moreno J, Carreira P, Julià A, Marsal S, Rodriguez-Rodriguez L; IMID Consortium.

Medicine (Baltimore). 2017 Jun;96(26):e7308. doi: 10.1097/MD.0000000000007308.

8.

Exploring the remission concept in rheumatoid arthritis with patients and rheumatologists: time for a new approach?

Acebes C, Andreu JL, Balsa A, Batlle E, de Toro-Santos J, García Llorente F, Hernández MV, Fernández-Gutiérrez B, Hidalgo-Calleja C, Mayordomo L, Naredo E, Narváez FJ, Ortiz AM, Pablos JL, Pérez-Sandoval T, Rodríguez-Lozano C, Sánchez-Pernaute O, Usón J, Negrón JB, Loza E, Carmona L, Gómez Castro S, Montoro Alvarez M.

Clin Exp Rheumatol. 2017 Sep-Oct;35(5):816-822. Epub 2017 May 8.

PMID:
28516881
9.

Vision-related Quality of Life in Patients with Non-infectious Uveitis: A Cross-sectional Study.

Arriola-Villalobos P, Abásolo L, García-Feijoo J, Fernández-Gutiérrez B, Méndez-Fernández R, Pato E, Díaz-Valle D, Rodriguez-Rodriguez L.

Ocul Immunol Inflamm. 2018;26(5):717-725. doi: 10.1080/09273948.2017.1285034. Epub 2017 Mar 21.

PMID:
28323495
10.

Encapsulation of allogeneic mesenchymal stem cells in alginate extends local presence and therapeutic function.

Leijs MJ, Villafuertes E, Haeck JC, Koevoet WJ, Fernandez-Gutierrez B, Hoogduijn MJ, Verhaar JA, Bernsen MR, van Buul GM, van Osch GJ.

Eur Cell Mater. 2017 Jan 30;33:43-58. doi: 10.22203/eCM.v033a04.

11.

Influence of coronary artery disease and subclinical atherosclerosis related polymorphisms on the risk of atherosclerosis in rheumatoid arthritis.

López-Mejías R, Corrales A, Vicente E, Robustillo-Villarino M, González-Juanatey C, Llorca J, Genre F, Remuzgo-Martínez S, Dierssen-Sotos T, Miranda-Filloy JA, Huaranga MA, Pina T, Blanco R, Alegre-Sancho JJ, Raya E, Mijares V, Ubilla B, Ferraz-Amaro I, Gómez-Vaquero C, Balsa A, López-Longo FJ, Carreira P, González-Álvaro I, Ocejo-Vinyals JG, Rodríguez-Rodríguez L, Fernández-Gutiérrez B, Castañeda S, Martín J, González-Gay MA.

Sci Rep. 2017 Jan 6;7:40303. doi: 10.1038/srep40303.

12.

Direct medical costs and their predictors in the EMAR-II cohort: "Variability in the management of rheumatoid arthritis and spondyloarthritis in Spain".

Leon L, Abasolo L, Fernandez-Gutierrez B, Jover JA, Hernandez-Garcia C.

Reumatol Clin. 2018 Jan - Feb;14(1):4-8. doi: 10.1016/j.reuma.2016.09.006. Epub 2016 Oct 31. English, Spanish.

13.

JC virus reactivation in patients with autoimmune rheumatic diseases treated with rituximab.

Domínguez-Mozo MI, Toledano-Martínez E, Rodríguez-Rodríguez L, García-Montojo M, Alvarez-Lafuente R, Fernández-Gutiérrez B.

Scand J Rheumatol. 2016 Nov;45(6):507-511. Epub 2016 Apr 11.

PMID:
27063911
14.

Influence of elevated-CRP level-related polymorphisms in non-rheumatic Caucasians on the risk of subclinical atherosclerosis and cardiovascular disease in rheumatoid arthritis.

López-Mejías R, Genre F, Remuzgo-Martínez S, González-Juanatey C, Robustillo-Villarino M, Llorca J, Corrales A, Vicente E, Miranda-Filloy JA, Magro C, Tejera-Segura B, Ramírez Huaranga MA, Pina T, Blanco R, Alegre-Sancho JJ, Raya E, Mijares V, Ubilla B, Mínguez Sánchez MD, Gómez-Vaquero C, Balsa A, Pascual-Salcedo D, López-Longo FJ, Carreira P, González-Álvaro I, Rodríguez-Rodríguez L, Fernández-Gutiérrez B, Ferraz-Amaro I, Castañeda S, Martín J, González-Gay MA.

Sci Rep. 2016 Aug 18;6:31979. doi: 10.1038/srep31979.

15.

Immunosuppressive Drug Discontinuation in Noninfectious Uveitis From Real-Life Clinical Practice: A Survival Analysis.

Abásolo L, Rosales Z, Díaz-Valle D, Gómez-Gómez A, Peña-Blanco RC, Prieto-García Á, Benítez-Del-Castillo JM, Pato E, García-Feijoo J, Fernández-Gutiérrez B, Rodriguez-Rodriguez L.

Am J Ophthalmol. 2016 Sep;169:1-8. doi: 10.1016/j.ajo.2016.06.007. Epub 2016 Jun 11.

PMID:
27296486
16.

Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies.

López-Isac E, Martín JE, Assassi S, Simeón CP, Carreira P, Ortego-Centeno N, Freire M, Beltrán E, Narváez J, Alegre-Sancho JJ; Spanish Scleroderma Group, Fernández-Gutiérrez B, Balsa A, Ortiz AM, González-Gay MA, Beretta L, Santaniello A, Bellocchi C, Lunardi C, Moroncini G, Gabrielli A, Witte T, Hunzelmann N, Distler JH, Riekemasten G, van der Helm-van Mil AH, de Vries-Bouwstra J, Magro-Checa C, Voskuyl AE, Vonk MC, Molberg Ø, Merriman T, Hesselstrand R, Nordin A, Padyukov L, Herrick A, Eyre S, Koeleman BP, Denton CP, Fonseca C, Radstake TR, Worthington J, Mayes MD, Martín J.

Arthritis Rheumatol. 2016 Sep;68(9):2338-44. doi: 10.1002/art.39730.

17.

Influence of baseline demographic and clinical characteristics in the visual outcome of intermediate uveitis: a survival analysis.

Abásolo L, Prieto-García Á, Díaz-Valle D, Benítez-Del-Castillo JM, Pato E, García-Feijoo J, Fernández-Gutiérrez B, Rodriguez-Rodriguez L.

Br J Ophthalmol. 2016 Dec;100(12):1651-1655. doi: 10.1136/bjophthalmol-2015-307774. Epub 2016 Mar 30.

PMID:
27030281
18.

Identification of IRX1 as a Risk Locus for Rheumatoid Factor Positivity in Rheumatoid Arthritis in a Genome-Wide Association Study.

Julià A, Blanco F, Fernández-Gutierrez B, González A, Cañete JD, Maymó J, Alperi-López M, Olivè A, Corominas H, Martínez-Taboada V, González-Álvaro I, Fernandez-Nebro A, Erra A, Sánchez-Fernández S, Alonso A, López-Lasanta M, Tortosa R, Codó L, Lluis Gelpi J, García-Montero AC, Bertranpetit J, Absher D, Myers RM, Tornero J, Marsal S.

Arthritis Rheumatol. 2016 Jun;68(6):1384-91. doi: 10.1002/art.39591.

19.

Influence of demographic and clinical factors on the mortality rate of a rheumatoid arthritis cohort: A 20-year survival study.

Abasolo L, Ivorra-Cortes J, Leon L, Jover JA, Fernandez-Gutierrez B, Rodriguez-Rodriguez L.

Semin Arthritis Rheum. 2016 Apr;45(5):533-8. doi: 10.1016/j.semarthrit.2015.10.016. Epub 2015 Nov 6.

PMID:
26639031
20.

PTGER4 gene variant rs76523431 is a candidate risk factor for radiological joint damage in rheumatoid arthritis patients: a genetic study of six cohorts.

Rodriguez-Rodriguez L, Ivorra-Cortes J, Carmona FD, Martín J, Balsa A, van Steenbergen HW, van der Helm-van Mil AH, González-Álvaro I, Fernandez-Gutiérrez B.

Arthritis Res Ther. 2015 Nov 5;17:306. doi: 10.1186/s13075-015-0830-z.

21.

Altered Expression of Wnt Signaling Pathway Components in Osteogenesis of Mesenchymal Stem Cells in Osteoarthritis Patients.

Tornero-Esteban P, Peralta-Sastre A, Herranz E, Rodríguez-Rodríguez L, Mucientes A, Abásolo L, Marco F, Fernández-Gutiérrez B, Lamas JR.

PLoS One. 2015 Sep 9;10(9):e0137170. doi: 10.1371/journal.pone.0137170. eCollection 2015.

22.

Variation at interleukin-6 receptor gene is associated to joint damage in rheumatoid arthritis.

Lopez-Lasanta M, Julià A, Maymó J, Fernández-Gutierrez B, Ureña-Garnica I, Blanco FJ, Cañete JD, Alperi-López M, Olivè A, Corominas H, Tornero J, Erra A, Almirall M, Palau N, Ortiz A, Avila G, Rodriguez-Rodriguez L, Alonso A, Tortosa R, Gonzalez-Alvaro I, Marsal S.

Arthritis Res Ther. 2015 Sep 4;17:242. doi: 10.1186/s13075-015-0737-8.

23.

Efficacy of supraspinatus tendon repair using mesenchymal stem cells along with a collagen I scaffold.

Tornero-Esteban P, Hoyas JA, Villafuertes E, Rodríguez-Bobada C, López-Gordillo Y, Rojo FJ, Guinea GV, Paleczny A, Lópiz-Morales Y, Rodriguez-Rodriguez L, Marco F, Fernández-Gutiérrez B.

J Orthop Surg Res. 2015 Aug 14;10:124. doi: 10.1186/s13018-015-0269-6.

24.

Signature of microRNA expression during osteogenic differentiation of bone marrow MSCs reveals a putative role of miR-335-5p in osteoarthritis.

Tornero-Esteban P, Rodríguez-Rodríguez L, Abásolo L, Tomé M, López-Romero P, Herranz E, González MA, Marco F, Moro E, Fernández-Gutiérrez B, Lamas JR.

BMC Musculoskelet Disord. 2015 Aug 5;16:182. doi: 10.1186/s12891-015-0652-9.

25.

A genome-wide association study identifies a new locus associated with the response to anti-TNF therapy in rheumatoid arthritis.

Julià A, Fernandez-Nebro A, Blanco F, Ortiz A, Cañete JD, Maymó J, Alperi-López M, Fernández-Gutierrez B, Olivè A, Corominas H, Erra A, Acosta-Colman I, Alonso A, López-Lasanta M, Tortosa R, Tornero J, Marsal S.

Pharmacogenomics J. 2016 Apr;16(2):147-50. doi: 10.1038/tpj.2015.31. Epub 2015 Apr 21.

PMID:
25896534
26.

Variation at FCGR2A and functionally related genes is associated with the response to anti-TNF therapy in rheumatoid arthritis.

Avila-Pedretti G, Tornero J, Fernández-Nebro A, Blanco F, González-Alvaro I, Cañete JD, Maymó J, Alperiz M, Fernández-Gutiérrez B, Olivé A, Corominas H, Erra A, Aterido A, López Lasanta M, Tortosa R, Julià A, Marsal S.

PLoS One. 2015 Apr 7;10(4):e0122088. doi: 10.1371/journal.pone.0122088. eCollection 2015.

27.

Lack of association between JAK3 gene polymorphisms and cardiovascular disease in Spanish patients with rheumatoid arthritis.

García-Bermúdez M, López-Mejías R, Genre F, Castañeda S, Corrales A, Llorca J, González-Juanatey C, Ubilla B, Miranda-Filloy JA, Pina T, Gómez-Vaquero C, Rodríguez-Rodríguez L, Fernández-Gutiérrez B, Balsa A, Pascual-Salcedo D, López-Longo FJ, Carreira P, Blanco R, Martín J, González-Gay MA.

Biomed Res Int. 2015;2015:318364. doi: 10.1155/2015/318364. Epub 2015 Mar 1.

28.

The rs3771863 single nucleotide polymorphism of the TACR1 gene is associated to a lower risk of sicca syndrome in fibromyalgia patients.

Rodriguez-Rodriguez L, Ramón Lamas J, Abásolo L, Baena S, Olano-Martin E, Collado A, Rivera J, Fernández-Gutiérrez B.

Clin Exp Rheumatol. 2015 Jan-Feb;33(1 Suppl 88):S33-40. Epub 2015 Mar 10.

PMID:
25786041
29.

Association of valine and leucine at HLA-DRB1 position 11 with radiographic progression in rheumatoid arthritis, independent of the shared epitope alleles but not independent of anti-citrullinated protein antibodies.

van Steenbergen HW, Raychaudhuri S, Rodríguez-Rodríguez L, Rantapää-Dahlqvist S, Berglin E, Toes RE, Huizinga TW, Fernández-Gutiérrez B, Gregersen PK, van der Helm-van Mil AH.

Arthritis Rheumatol. 2015 Apr;67(4):877-86. doi: 10.1002/art.39018.

30.

A genetic study on C5-TRAF1 and progression of joint damage in rheumatoid arthritis.

van Steenbergen HW, Rodríguez-Rodríguez L, Berglin E, Zhernakova A, Knevel R, Ivorra-Cortés J, Huizinga TW, Fernández-Gutiérrez B, Gregersen PK, Rantapää-Dahlqvist S, van der Helm-van Mil AH.

Arthritis Res Ther. 2015 Jan 8;17:1. doi: 10.1186/s13075-014-0514-0.

31.

Lack of replication of interactions between polymorphisms in rheumatoid arthritis susceptibility: case-control study.

Ferreiro-Iglesias A, Calaza M, Perez-Pampin E, Lopez Longo FJ, Marenco JL, Blanco FJ, Narvaez J, Navarro F, Cañete JD, de la Serna AR, Gonzalez-Alvaro I, Herrero-Beaumont G, Pablos JL, Balsa A, Fernandez-Gutierrez B, Caliz R, Gomez-Reino JJ, Gonzalez A.

Arthritis Res Ther. 2014 Sep 27;16(5):436. doi: 10.1186/s13075-014-0436-x.

32.

Selected reaction monitoring assays in mesenchymal stem cells from osteoarthritis patients.

Camafeita E, Lamas JR, Calvo E, Tornero-Esteban P, López JA, Fernández-Gutiérrez B.

Clin Proteomics. 2014 Sep 1;11(1):33. doi: 10.1186/1559-0275-11-33. eCollection 2014.

33.

Osteoprotegerin CGA haplotype protection against cerebrovascular complications in anti-CCP negative patients with rheumatoid arthritis.

Genre F, López-Mejías R, García-Bermúdez M, Castañeda S, González-Juanatey C, Llorca J, Corrales A, Ubilla B, Miranda-Filloy JA, Pina T, Gómez-Vaquero C, Rodríguez-Rodríguez L, Fernández-Gutiérrez B, Balsa A, Pascual-Salcedo D, López-Longo FJ, Carreira P, Blanco R, González-Álvaro I, Martín J, González-Gay MA.

PLoS One. 2014 Sep 3;9(9):e106823. doi: 10.1371/journal.pone.0106823. eCollection 2014.

34.

Rheumatoid arthritis: genetic variants as biomarkers of cardiovascular disease.

Rodriguez-Rodriguez L, López-Mejias R, Fernández-Gutiérrez B, Balsa A, González-Gay MA, Martín J.

Curr Pharm Des. 2015;21(2):182-201. Review.

PMID:
25163740
35.

Interferon regulatory factor 5 genetic variants are associated with cardiovascular disease in patients with rheumatoid arthritis.

García-Bermúdez M, López-Mejías R, Genre F, Castañeda S, Llorca J, González-Juanatey C, Corrales A, Ubilla B, Miranda-Filloy JA, Pina T, Gómez-Vaquero C, Rodríguez-Rodríguez L, Fernández-Gutiérrez B, Balsa A, Pascual-Salcedo D, López-Longo FJ, Carreira P, Blanco R, Martín J, González-Gay MA.

Arthritis Res Ther. 2014 Jul 10;16(4):R146. doi: 10.1186/ar4608.

36.

Lack of association between ABO, PPAP2B, ADAMST7, PIK3CG, and EDNRA and carotid intima-media thickness, carotid plaques, and cardiovascular disease in patients with rheumatoid arthritis.

López-Mejías R, Genre F, García-Bermúdez M, Ubilla B, Castañeda S, Llorca J, González-Juanatey C, Corrales A, Miranda-Filloy JA, Pina T, Gómez-Vaquero C, Rodríguez-Rodríguez L, Fernández-Gutiérrez B, Balsa A, Pascual-Salcedo D, López-Longo FJ, Carreira P, Blanco R, Martín J, González-Gay MA.

Mediators Inflamm. 2014;2014:756279. doi: 10.1155/2014/756279. Epub 2014 Mar 25.

37.

[Study of the role of miRNA in mesenchymal stem cells isolated from osteoarthritis patients].

Tornero-Esteban P, Hoyas JA, Villafuertes E, Garcia-Bullón I, Moro E, Fernández-Gutiérrez B, Marco F.

Rev Esp Cir Ortop Traumatol. 2014 May-Jun;58(3):138-43. doi: 10.1016/j.recot.2013.12.004. Epub 2014 Feb 28. Spanish.

PMID:
24582835
38.

Recommendations for the management of cardiovascular risk in patients with rheumatoid arthritis: scientific evidence and expert opinion.

Martín-Martínez MA, González-Juanatey C, Castañeda S, Llorca J, Ferraz-Amaro I, Fernández-Gutiérrez B, Díaz-González F, González-Gay MA.

Semin Arthritis Rheum. 2014 Aug;44(1):1-8. doi: 10.1016/j.semarthrit.2014.01.002. Epub 2014 Jan 24. Review.

PMID:
24560170
39.

Single-nucleotide polymorphisms at the 9p21.3 genomic region not associated with the risk of cardiovascular disease in patients with rheumatoid arthritis.

García-Bermúdez M, López-Mejías R, Genre F, Castañeda S, González-Juanatey C, Llorca J, Corrales A, Miranda-Filloy JA, Pina T, Gómez-Vaquero C, Rodríguez-Rodríguez L, Fernández-Gutiérrez B, Pascual-Salcedo D, Balsa A, López-Longo FJ, Carreira P, Blanco R, González-Álvaro I, Martín J, González-Gay MA.

Tissue Antigens. 2013 Dec;82(6):405-9. doi: 10.1111/tan.12227. Epub 2013 Oct 15.

PMID:
24498997
40.

SMAD3 rs17228212 gene polymorphism is associated with reduced risk to cerebrovascular accidents and subclinical atherosclerosis in anti-CCP negative Spanish rheumatoid arthritis patients.

García-Bermúdez M, López-Mejías R, Genre F, Castañeda S, González-Juanatey C, Llorca J, Corrales A, Miranda-Filloy JA, Rueda-Gotor J, Gómez-Vaquero C, Rodríguez-Rodríguez L, Fernández-Gutiérrez B, Pascual-Salcedo D, Balsa A, López-Longo FJ, Carreira P, Blanco R, González-Álvaro I, Martín J, González-Gay MA.

PLoS One. 2013 Oct 21;8(10):e77695. doi: 10.1371/journal.pone.0077695. eCollection 2013. Erratum in: PLoS One. 2013;8(11). doi:10.1371/annotation/3fc037c1-2585-4d2b-a781-e04ab7b3bfeb.

41.

The 11q23.3 genomic region-rs964184-is associated with cardiovascular disease in patients with rheumatoid arthritis.

López-Mejías R, Genre F, García-Bermúdez M, Castañeda S, González-Juanatey C, Llorca J, Corrales A, Miranda-Filloy JA, Rueda-Gotor J, Gómez-Vaquero C, Rodríguez-Rodríguez L, Fernández-Gutiérrez B, Balsa A, Pascual-Salcedo D, López-Longo FJ, Carreira P, Blanco R, González-Álvaro I, Martín J, González-Gay MA.

Tissue Antigens. 2013 Nov;82(5):344-7. doi: 10.1111/tan.12217.

PMID:
24131021
42.

Weather conditions may worsen symptoms in rheumatoid arthritis patients: the possible effect of temperature.

Abasolo L, Tobías A, Leon L, Carmona L, Fernandez-Rueda JL, Rodriguez AB, Fernandez-Gutierrez B, Jover JA.

Reumatol Clin. 2013 Jul-Aug;9(4):226-8. doi: 10.1016/j.reuma.2012.09.006. Epub 2013 Feb 4.

43.

Leflunomide discontinuation in rheumatoid arthritis and influence of associated disease-modifying anti-rheumatic drugs: a survival analysis.

Rodriguez-Rodriguez L, Jover-Jover JA, Fontsere O, Peña-Blanco RC, León L, Fernández-Gutierrez B, Abásolo L.

Scand J Rheumatol. 2013;42(6):433-6. doi: 10.3109/03009742.2013.785590. Epub 2013 Jun 7.

PMID:
23742043
44.

Expression of human endogenous retrovirus HERV-K18 is associated with clinical severity in osteoarthritis patients.

Garcia-Montojo M, Varade J, Villafuertes E, de La Hera B, Hoyas-Fernandez J, Domínguez-Mozo MI, Rodriguez-Rodriguez L, Tornero-Esteban P, Arias-Leal A, León L, Lamas JR, Alvarez-Lafuente R, Urcelay E, Fernandez-Gutierrez B.

Scand J Rheumatol. 2013;42(6):498-504. doi: 10.3109/03009742.2013.779021. Epub 2013 May 11.

PMID:
23662747
45.

GWAS replication study confirms the association of PDE3A-SLCO1C1 with anti-TNF therapy response in rheumatoid arthritis.

Acosta-Colman I, Palau N, Tornero J, Fernández-Nebro A, Blanco F, González-Alvaro I, Cañete JD, Maymó J, Ballina J, Fernández-Gutiérrez B, Olivé A, Corominas H, Erra A, Canela-Xandri O, Alonso A, López Lasanta M, Tortosa R, Julià A, Marsal S.

Pharmacogenomics. 2013 May;14(7):727-34. doi: 10.2217/pgs.13.60.

PMID:
23651021
46.

Epistatic interaction between BANK1 and BLK in rheumatoid arthritis: results from a large trans-ethnic meta-analysis.

Génin E, Coustet B, Allanore Y, Ito I, Teruel M, Constantin A, Schaeverbeke T, Ruyssen-Witrand A, Tohma S, Cantagrel A, Vittecoq O, Barnetche T, Le Loët X, Fardellone P, Furukawa H, Meyer O, Fernández-Gutiérrez B, Balsa A, González-Gay MA, Chiocchia G, Tsuchiya N, Martin J, Dieudé P.

PLoS One. 2013 Apr 30;8(4):e61044. doi: 10.1371/journal.pone.0061044. Print 2013.

47.

Role of the human endogenous retrovirus HERV-K18 in autoimmune disease susceptibility: study in the Spanish population and meta-analysis.

de la Hera B, Varadé J, García-Montojo M, Lamas JR, de la Encarnación A, Arroyo R, Fernández-Gutiérrez B, Alvarez-Lafuente R, Urcelay E.

PLoS One. 2013 Apr 25;8(4):e62090. doi: 10.1371/journal.pone.0062090. Print 2013.

48.

Alternative splicing and proteolytic rupture contribute to the generation of soluble IL-6 receptors (sIL-6R) in rheumatoid arthritis.

Lamas JR, Rodríguez-Rodríguez L, Tornero-Esteban P, Villafuertes E, Hoyas J, Abasolo L, Varadé J, Alvarez-Lafuente R, Urcelay E, Fernández-Gutiérrez B.

Cytokine. 2013 Mar;61(3):720-3. doi: 10.1016/j.cyto.2012.12.025. Epub 2013 Jan 29.

PMID:
23375120
49.

Health-related quality of life as a main determinant of access to rheumatologic care.

Leon L, Jover JA, Loza E, Zunzunegui MV, Lajas C, Vadillo C, Fontsere O, Rodriguez-Rodriguez L, Martinez C, Fernandez-Gutierrez B, Abasolo L.

Rheumatol Int. 2013 Jul;33(7):1797-804. doi: 10.1007/s00296-012-2599-6. Epub 2013 Jan 11.

PMID:
23306593
50.

Study of association of CD40-CD154 gene polymorphisms with disease susceptibility and cardiovascular risk in Spanish rheumatoid arthritis patients.

García-Bermúdez M, González-Juanatey C, López-Mejías R, Teruel M, Corrales A, Miranda-Filloy JA, Castañeda S, Balsa A, Fernández-Gutierrez B, González-Álvaro I, Gómez-Vaquero C, Blanco R, Llorca J, Martín J, González-Gay MA.

PLoS One. 2012;7(11):e49214. doi: 10.1371/journal.pone.0049214. Epub 2012 Nov 15.

Supplemental Content

Loading ...
Support Center